Discontinuation report APO-TICAGRELOR
| Report ID | 257747 |
| Drug Identification Number | 02482622 |
| Brand name | APO-TICAGRELOR |
| Common or Proper name | Nom commun ou nom propre |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TICAGRELOR |
| Strength(s) | 60MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | Taille de l’emballage |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Raw material availability |
| Anticipated discontinuation date | 2022-01-02 |
| Actual discontinuation date | 2024-08-17 |
| Remaining supply date | |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2025-11-20 | English | Compare |
| v2 | 2025-11-19 | French | Compare |
| v1 | 2025-11-19 | English | Compare |
Showing 1 to 3 of 3